Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective
AlbACS-1R
Albumin Utilization for Intravascular Volume Replacement in Adult Cardiac Surgical Patients : A Multi-centre, Retrospective, Cohort Study
1 other identifier
observational
505
1 country
10
Brief Summary
All heart surgery patients universally require hydration, which is given through a vein in the arm, but practices for treating patients are not universal. There are disagreements about whether crystalloids should be used alone or in combination with albumin. This question has important implications because albumin is an expensive blood product in relatively limited supply, and 20% of its use is by heart surgery patients. The goal of this study is to learn more about how crystalloids and albumin are used during heart surgery, as well as, key patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedStudy Start
First participant enrolled
May 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedNovember 26, 2025
November 1, 2025
1.5 years
February 21, 2024
November 20, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Albumin
Type, dose and timing of administration, the setting in which it was ordered, indication for use, and the type of provider responsible for the patient at administration (surgeon, anesthesiologist, intensivist, nurse practitioner).
On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.
Crystalloid, volume dose and type administered
Type and volume of crystalloid given (Normal saline, Ringer's Lactate, Plasmalyte-148, and others), as well as the setting of administration will be recorded.
On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.
Study Arms (1)
Cardiac Surgery Patients
Adult (≥18 years old) patients who have undergone cardiac surgery.
Eligibility Criteria
The study will include up to 500 adult (≥18 years old) patients who have undergone major cardiac surgery. All adult (≥18 years old) patients who have undergone cardiac surgery (with or without the use of cardio-pulmonary bypass) will be eligible. There are no specific exclusion criteria.
You may qualify if:
- Adult (≥18 years old)
- Cardiac surgery with the use of cardiopulmonary bypass
- Cardiac surgery without the use of cardiopulmonary bypass
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- Kingston Health Sciences Centrecollaborator
- Unity Health Torontocollaborator
- McMaster Universitycollaborator
- Sunnybrook Health Sciences Centrecollaborator
- London Health Sciences Centrecollaborator
- The Ottawa Hospitalcollaborator
- Vancouver General Hospitalcollaborator
- Royal Columbian Hospital Foundationcollaborator
- Nova Scotia Health Authoritycollaborator
Study Sites (10)
Royal Columbian Hospital
New Westminster, British Columbia, V3L 3W7, Canada
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 3A6, Canada
McMaster University Medical Centre
Hamilton, Ontario, Canada
Kingston Health Sciences Centre
Kingston, Ontario, K7L 3N6, Canada
London Health Science Centre
London, Ontario, N6A 5A5, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
Toronto General Hospital - University Health Network
Toronto, Ontario, M5G 2C4, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Keyvan Karkouti, MD MSc FRCPC
Toronto General Hospital - University Health Network
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2024
First Posted
March 21, 2024
Study Start
May 23, 2024
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share